JIADE Limited Launches $3M Direct Equity Offering

BenzingaBenzinga
|||1 min read
Key Takeaway

JIADE Limited launches $3M direct equity offering of 12M shares at $0.25 each. Stock fell 8.13% on announcement; potential $12M if all options exercised.

JIADE Limited Launches $3M Direct Equity Offering

JIADE Limited (NASDAQ: JDZG) announced a registered direct offering of 12 million Class A ordinary shares priced at $0.25 per share, generating approximately $3 million in gross proceeds. The company intends to allocate the capital toward general corporate purposes, though specific deployment plans were not detailed in the announcement.

The offering structure includes an option for investors to purchase an additional 36 million shares within a 30-day period, which could expand total proceeds to approximately $12 million if fully exercised. The company did not disclose participation terms or investor composition in the initial announcement.

Market reaction to the offering was negative, with JIADE shares declining 8.13% on the announcement day. The stock currently trades near its 52-week low of $0.20, reflecting broader pressure on the security amid recent trading patterns.

Source: Benzinga

Back to newsPublished Feb 19

Related Coverage

GlobeNewswire Inc.

17EdTech Posts Narrower Loss Despite Revenue Decline as AI Product Gains Traction

17EdTech reports Q4 revenue growth of 6.4% YoY and significant margin expansion, though full-year revenues declined 44% due to business model shift. New AI product 'Yiqi Aixue' shows strong pre-sale demand.

YQ
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
Investing.com

D-Wave's 44% Plunge Masks Quantum Leap: Growth Story vs. Valuation Reality

D-Wave ($QBTS) fell 44% in 2026 despite strong bookings exceeding 2025 totals and $30M in major deals. Analysts see 132% upside, but 237x sales valuation remains extreme.

QBTS
GlobeNewswire Inc.

OneMain Holdings Faces Multi-State Securities Probe Over Alleged Lending Fraud

Pomerantz Law Firm investigates $OMF following multi-state lawsuit alleging deceptive lending practices. Stock tumbles 5.38% on fraud allegations.

OMF
GlobeNewswire Inc.

Harrow Raises $50M via Senior Notes as Ophthalmic Firm Funds Growth

Harrow prices $50M in senior unsecured notes due 2030, expanding existing debt facility for product development and strategic initiatives.

HROW
GlobeNewswire Inc.

Boston Scientific Faces Securities Fraud Lawsuit Over Overstated EP Growth Claims

Boston Scientific faces class action lawsuit alleging material misstatements about electrophysiology growth. Stock fell 17.6% after disclosing slower market growth and competitive pressures.

BSX